4-(2-Chloropyridin-3-yl)-2-(pyridin-4-yl)pyrimidine

Catalog No. :
ACQXDY008
CAS No. :
1312186-10-9
Molecular Formula :
C14H9ClN4
Molecular Weight :
268.71

IUPAC Name:4-(2-chloropyridin-3-yl)-2-(pyridin-4-yl)pyrimidine

4-(2-Chloropyridin-3-yl)-2-(pyridin-4-yl)pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg90%$120.00Login to see priceInquiryInquiry
10mg90%$147.00Login to see priceInquiryInquiry
50mg90%$207.00Login to see priceInquiryInquiry
100mg90%$273.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2-Chloropyridin-3-yl)-2-(pyridin-4-yl)pyrimidine
IUPAC Name4-(2-chloropyridin-3-yl)-2-(pyridin-4-yl)pyrimidine
MDL No.MFCD19381781
Molecular FormulaC14H9ClN4
Molecular Weight268.71
SMILESClC1=NC=CC=C1C2=NC(C3=CC=NC=C3)=NC=C2
InChI KeyPIYVABICEOCBNY-UHFFFAOYSA-N
Synonym4-(2-chloropyridin-3-yl)-2-(pyridin-4-yl)pyrimidine;Pyrimidine, 4-(2-chloro-3-pyridinyl)-2-(4-pyridinyl)-
CAS No.1312186-10-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQXDY008 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIDLP204 route compound structure diagram
    ACIDLP204913835-65-1 In Stock
  4. Then
  5. ACQXDY008 route product structure diagram
    ACQXDY0081312186-10-9
Inquiry

2. ACQXDY008 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMAZP706 route compound structure diagram
    ACMAZP706381248-04-0 In Stock
  4. Then
  5. ACQXDY008 route product structure diagram
    ACQXDY0081312186-10-9
Inquiry

Comments (0)